Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sixty patients meeting Diagnostic and Statistical Manual of Mental Disorders (4th ed.: American Psychiatric Association, 1994) criteria for generalized social phobia were assigned to cognitive therapy (CT), fluoxetine plus self-exposure (FLU + SE), or placebo plus self-exposure (PLA + SE). At posttreatment (16 weeks), the medication blind was broken. CT and FLU + SE patients then entered a 3-month booster phase. Assessments were at pretreatment, midtreatment, posttreatment, end of booster phase, and 12-month follow-up. Significant improvements were observed on most measures in all 3 treatments. On measures of social phobia, CT was superior to FLU + SE and PLA + SE at midtreatment and at posttreatment. FLU + SE and PLA + SE did not differ. CT remained superior to FLU + SE at the end of the booster period and at 12-month follow-up. On general mood measures, there were few differences between the treatments

Original publication

DOI

10.1037/0022-006X.71.6.1058

Type

Journal article

Journal

J Consult Clin Psychol

Publication Date

12/2003

Volume

71

Pages

1058 - 1067

Keywords

Adult, Cognitive Therapy, Combined Modality Therapy, Desensitization, Psychologic, Female, Fluoxetine, Follow-Up Studies, Humans, Male, Phobic Disorders, Retreatment, Serotonin Uptake Inhibitors, Treatment Outcome